Senate Passes Bill With FDA Review Deadlines For All OTC TEAs
This article was originally published in The Tan Sheet
Executive Summary
The Senate approves by unanimous consent legislation to speed reviews for all OTC ingredient TEAs. But the House version addresses only sunscreen TEAs, and any agreement the two chambers make on the legislation likely will have to wait for the lame duck session.